| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |